Tulsa癌症患者Sara Snow现在在当地接受治疗,这要归功于新的医院伙伴关系。 Tulsa cancer patient Sara Snow now receives treatment locally, thanks to a new hospital partnership.

Tulsa癌症患者Sara Snow现在在离家很近的地方接受治疗,这要归功于保健史蒂芬森癌症中心与Hillcrest的合作。 A Tulsa cancer patient, Sara Snow, now receives her treatments close to home thanks to a partnership between the OU Health Stephenson Cancer Center and Hillcrest. Snow, 被诊断为第四阶段神经内分泌癌, 先前曾前往俄克拉荷马城接受治疗。 Snow, diagnosed with stage 4 neuroendocrine carcinoma, previously traveled to Oklahoma City for treatments. 新的伙伴关系将国家癌症研究所指定的护理工作带给图尔萨。 The new partnership brings National Cancer Institute-designated care to Tulsa. 白雪使用新批准的药物Tarlatamab治疗,这是双性T细胞诱导疗法的一部分。 Snow is treated with a newly approved drug, Tarlatamab, part of a bispecific T-cell engager therapy. 这一发展使当地病人更容易获得癌症护理,减轻压力。 This development makes cancer care more accessible and less stressful for local patients.